About
Mission and Values
Leadership Team
Management Team
Scientific Advisory Board
Corporate Governance
Technology
Introduction
Allogeneic CAR T Cell Therapy
OnCARlytics (CF33-CD19)
Oncolytic Virus (CF33)
B-Cell Immunotherapies
Mimotopes
Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors
ASX Announcements
Investor Presentations
Conference Presentations
Analyst Coverage
Annual Reports
Financial Report
Half Yearly Report
Quarterly Report
Live Share Price
Media
Videos
Newsletters
Target Market Determination
ESG Reports
Careers
Contact
About
Mission and Values
Leadership Team
Management Team
Scientific Advisory Board
Corporate Governance
Technology
Introduction
Allogeneic CAR T Cell Therapy
OnCARlytics (CF33-CD19)
Oncolytic Virus (CF33)
B-Cell Immunotherapies
Mimotopes
Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors
ASX Announcements
Investor Presentations
Conference Presentations
Analyst Coverage
Annual Reports
Financial Report
Half Yearly Report
Quarterly Report
Live Share Price
Media
Videos
Newsletters
Target Market Determination
ESG Reports
Careers
Contact
ESG Reports
Investors
ASX Announcements
Investor Presentations
Conference Presentations
Analyst Coverage
Annual Reports
Financial Report
Half Yearly Report
Quarterly Report
Live Share Price
Media
Videos
Newsletters
Target Market Determination
ESG Reports
Imugene ESG Report 2023
Download
Imugene ESG Report 2022
Download
